Otsuka (4768) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
12 Nov, 2025Executive summary
Net sales for January–September 2025 reached ¥1,005,719 million, up 22.3% year-over-year; operating profit rose 27.5% to ¥66,529 million; profit attributable to owners of parent increased 27.0% to ¥46,531 million.
Comprehensive income increased 38.5% year-over-year to ¥49,579 million for the nine-month period.
Strong third quarter with net sales of ¥310,586 million, up 23.0% year-over-year, and operating profit up 30.2%.
Financial highlights
Consolidated ordinary profit for the nine months was ¥68,071 million, up 26.0% year-over-year.
Gross profit for the nine months ended September 30, 2025, was ¥186,324 million, up from ¥163,879 million year-over-year.
Basic earnings per share for the period was ¥122.71, reflecting a two-for-one stock split effective April 1, 2024.
Total assets increased to ¥696,258 million as of September 30, 2025, from ¥673,903 million at the end of 2024.
Net assets rose to ¥377,203 million, with an equity ratio of 53.5%.
Outlook and guidance
Revised full-year plan projects net sales of ¥1,261,000 million and operating profit of ¥86,200 million for FY2025.
Profit attributable to owners of parent is forecast at ¥58,700 million, with basic EPS at ¥154.80.
Latest events from Otsuka
- Double-digit sales and profit growth, with stable outlook and higher dividends forecast.4768
Q4 202510 Feb 2026 - Strong first-half growth and raised full-year outlook, supported by a recent stock split.4768
Q2 202428 Oct 2025 - Double-digit profit and sales growth driven by both business segments, with positive outlook.4768
Q3 202428 Oct 2025 - Double-digit sales and profit growth in FY2024, with strong outlook and milestone dividend.4768
Q4 202428 Oct 2025 - Q1 2025 delivered strong sales and profit growth, with positive full-year guidance.4768
Q1 202528 Oct 2025 - Double-digit sales and profit growth in H1 2025, with upwardly revised full-year outlook.4768
Q2 202528 Oct 2025